Midnolin-proteasome pathway for protein degradation
- PMID: 38084259
- PMCID: PMC10710823
- DOI: 10.1002/mco2.450
Midnolin-proteasome pathway for protein degradation
Abstract
Overexpression of immediate-early genes (IEGs) has been linked to was associated with cancer progression and prognosis. In a recent study, Gu et al. reported the midnolin-proteasome pathway, a novel ubiquitin-independent proteasomal degradation. 1 The study provided the mechanism of rapid degradation for nuclear proteins with high unsteadiness. Targeting the midnolin-proteasome pathway might be beneficial for cancer therapy.
© 2023 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The author declares that he has no competing interests.
Figures

References
-
- Healy S, Khan P, Davie JR. Immediate early response genes and cell transformation. Pharmacol Therap. 2013;137(1):64‐77. - PubMed
LinkOut - more resources
Full Text Sources